Gabriel Braley

2.9k total citations · 1 hit paper
10 papers, 1.7k citations indexed

About

Gabriel Braley is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Gabriel Braley has authored 10 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Gabriel Braley's work include Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Gabriel Braley is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Gabriel Braley collaborates with scholars based in United States. Gabriel Braley's co-authors include Deepak Cyril D’Souza, Thomas B. Cooper, John H. Krystal, Ralitza Gueorguieva, Edward Perry, Lisa Macdougall, Yu‐Te Wu, Kimberlee Forselius-Bielen, Steven Madonick and Mohini Ranganathan and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Gabriel Braley

10 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

2004 764 citations Deepak Cyril D’Souza, Edward Perry et al. Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel Braley United States	9	1.4k	795	477	318	226	10	1.7k
Amir Englund United Kingdom	16	1.2k 0.9×	366 0.5×	311 0.7×	224 0.7×	222 1.0×	27	1.4k
Amie S. Ward United States	24	984 0.7×	1.2k 1.5×	263 0.6×	411 1.3×	235 1.0×	37	2.0k
Hendrika H. van Hell Netherlands	15	945 0.7×	548 0.7×	211 0.4×	419 1.3×	152 0.7×	21	1.3k
Lisa Macdougall United States	5	786 0.6×	505 0.6×	269 0.6×	241 0.8×	123 0.5×	5	1.1k
Christopher D. Verrico United States	23	672 0.5×	830 1.0×	199 0.4×	251 0.8×	280 1.2×	58	1.5k
Gráinne Schäfer United Kingdom	10	959 0.7×	372 0.5×	205 0.4×	254 0.8×	169 0.7×	12	1.1k
Maria Sabrina Spano Italy	21	817 0.6×	852 1.1×	182 0.4×	148 0.5×	89 0.4×	26	1.4k
Nigel Tunstall United Kingdom	12	651 0.5×	400 0.5×	275 0.6×	473 1.5×	241 1.1×	16	1.2k
Alessandra Paparelli United Kingdom	11	527 0.4×	278 0.3×	445 0.9×	160 0.5×	260 1.2×	17	1.0k
Erica Zamberletti Italy	21	1.1k 0.8×	754 0.9×	105 0.2×	307 1.0×	80 0.4×	35	1.4k

Countries citing papers authored by Gabriel Braley

Since Specialization

Citations

This map shows the geographic impact of Gabriel Braley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Braley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Braley more than expected).

Fields of papers citing papers by Gabriel Braley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Braley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Braley. The network helps show where Gabriel Braley may publish in the future.

Co-authorship network of co-authors of Gabriel Braley

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Braley. A scholar is included among the top collaborators of Gabriel Braley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Braley. Gabriel Braley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Balice‐Gordon, Rita J., G.D. Honey, Christopher H. Chatham, et al.. (2020). A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity. The International Journal of Neuropsychopharmacology. 23(5). 287–299. 9 indexed citations

Nichols, Alice I., Shannon L. Lubaczewski, Yali Liang, et al.. (2014). Open-label, 2-period sequential drug interaction study to evaluate the effect of a 100-mg dose of desvenlafaxine on the pharmacokinetics of tamoxifen when coadministered in healthy postmenopausal female subjects. International Journal of Clinical Pharmacology and Therapeutics. 52(10). 830–841. 6 indexed citations

Ranganathan, Mohini, Michelle Carbuto, Gabriel Braley, et al.. (2012). Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology. 15(9). 1251–1264. 21 indexed citations

Carbuto, Michelle, R. Andrew Sewell, Ashley Williams, et al.. (2011). The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories. Psychopharmacology. 219(3). 885–896. 25 indexed citations

Ranganathan, Mohini, Gabriel Braley, Brian Pittman, et al.. (2008). The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology. 203(4). 737–744. 89 indexed citations

D’Souza, Deepak Cyril, Gabriel Braley, Michael S. Vendetti, et al.. (2008). Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans. Psychopharmacology. 198(4). 587–603. 94 indexed citations

D’Souza, Deepak Cyril, Mohini Ranganathan, Gabriel Braley, et al.. (2008). Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis. Neuropsychopharmacology. 33(10). 2505–2516. 208 indexed citations

D’Souza, Deepak Cyril, Roberto Gil, Steven Madonick, et al.. (2006). Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia. Neuropsychopharmacology. 31(12). 2767–2775. 39 indexed citations

D’Souza, Deepak Cyril, Walid Abi‐Saab, Steven Madonick, et al.. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry. 57(6). 594–608. 452 indexed citations

10.

D’Souza, Deepak Cyril, Edward Perry, Lisa Macdougall, et al.. (2004). The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. Neuropsychopharmacology. 29(8). 1558–1572. 764 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact